This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Beijing University of Technology, The University of Queensland. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2019-2021
Title: Claudia Ann Ireland: Innovator in Neuroprotective Agents
Introduction
Claudia Ann Ireland is a distinguished inventor based in Aspendale, Australia. She has made significant contributions to the field of neuroprotective agents, particularly through her innovative work with spider venom peptides. With a total of two patents to her name, her research has the potential to impact neuroprotection and therapeutic applications.
Latest Patents
Claudia's latest patents focus on neuroprotective agents derived from spider venom peptides. The inventions relate to disulfide-rich peptides extracted from spider venom and their application as neuroprotective agents. Additionally, her patents encompass nucleic acid molecules that encode these peptides, as well as constructs and host cells that incorporate those nucleic acid molecules.
Career Highlights
Throughout her career, Claudia has worked with prestigious institutions, including the University of Queensland and Beijing University of Technology. Her research has garnered attention for its innovative approach to neuroprotection, showcasing her expertise in the field.
Collaborations
Claudia has collaborated with notable individuals such as Glenn King and Lachlan Douglas Rash, contributing to the advancement of her research and the development of her patents.
Conclusion
Claudia Ann Ireland stands out as a pioneering inventor in the realm of neuroprotective agents, with her work promising to enhance our understanding and treatment of neurodegenerative conditions. Her contributions to science and innovation are commendable and continue to inspire future research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile